NSEShareholders meeting22 Aug 2026 · 22 Aug 2026, 06:16 pm
Shareholders meeting
Par Drugs and Chemicals Limited · PAR
✦ AI Summaryshareholders_meeting
Par Drugs and Chemicals Limited has announced the 27th Annual General Meeting (AGM) to be held on September 26, 2026, at Hotel Tara Suns in Vadodara, Gujarat. The meeting will consider the audited standalone financial statements for the financial year ended March 31, 2026, and other business items.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Par Drugs And Chemicals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 26, 2026
Attachments (1)
📄pdf
Download →
PAR_22082026181427_SignedIntimationof27AGM2026.pdf
View document text
PAR/CS/NSE/2026-27/16 Date: 22/08/2026
The Manager
Listing department,
National Stock Exchange of India Limited
Exchange Plaza, C-1, Block-G,
Bandra Kurla Complex, Bandra (E),
Mumbai- 400 051
Maharashtra
Subject: Intimation of 27th Annual General Meeting, Cut-off Date, e-voting period and other information
Ref.: Symbol- PAR, ISIN: INE04LG01015
Dear Sir/Madam,
Pursuant to the provisions of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we
would like to inform that the 27th Annual General Meeting of the members of the Company is scheduled to be
as per followings:
Meeting Number: 27th Annual General Meeting
Date: 26th Day of September, 2026
Day: Saturday
Venue: Hotel Tara Suns, B/h Yash Complex, B/s Sonal Park, G.E.R.I. Road, Gotri, Vadodara -
390021, Gujarat, India
Time: 11:00 AM IST
Mode: Physical
The relevant dates w.r.t. Annual General Meeting are as under.
Sr. Particulars Relevant Date
1. Cut-off/Record date: Friday, September 18, 2026
For the purpose of voting through remote
e-voting, Venue voting at the time of the AGM
and attending the AGM.
2. Commencement of E-voting Tuesday, 22nd September, 2026 from 09:00 A.M. IST
onwards
3. End of e-voting Friday, 25th September, 2026 till 5:00 P.M. IST
Page 1 of 2
The Company has arranged with MUFG INTIME INDIA PRIVATE LIMITED (Erstwhile known as Link Intime India
Private Limited) (“RTA” of the Company) an agency for providing facility of e-voting for the ensuring AGM.
The voting rights of the Members shall be in proportion to their shares of the paid up equity share capital of
the Company, as on the cut-off date, being Friday, September 18, 2026
The above intimation shall be treated as due compliance of respective provisions under the Companies Act,
2013 and SEBI (Listing obligation and Disclosure Requirements) Regulations, 2015.
The Annual Report for F.Y. 2025-26 will be sent to shareholders and all concerned with due course. We request
to take the same on your records and disseminate the same to the members.
Kindly take on the record and acknowledge the receipt.
Yours Faithfully,
For PAR DRUGS AND CHEMICALS LIMITED
(Mr. Sanket B. Trivedi)
Company Secretary & Compliance Officer
Membership No.: FCS-13800
Encl: Notice of 27th AGM
Copy to:
National Securities Depository Central Depository Services MUFG Intime India Private
Limited (India) Limited Limited
4th Floor, Trade World, A Wing, “A” Wing, 25th Floor, Marathon Futurex, Office: 506 to 508 Amarnath
Kamala Mills Compound, Mafatlal Mills Compounds, Business Centre, -1 (ABC-1),
Senapati Bapat Marg, Lower Parel, N M Joshi Marg, Lower Parel (E), Besides Gala Business Centre,
Mumbai – 400013 Mumbai – 400013 Near St. Xaviers College,
Off C. G. Road, Navrangpura,
Ahmedabad – 380009
Page 2 of 2
Par Drugs And Chemicals Limited
CIN: L24117GJ1999PLC035512
Registered office: 815, Nilamber Triumph, Gotri Vasna Road,
Vadodara-390007, Gujarat, India
Phone no.: 0265-2991021, 0278-2447013
Website: www.pardrugs.com Email: investors@pardrugs.com
NOTICE OF 27TH ANNUAL GENERAL MEETING TO MEMBERS
Notice is hereby given that the Twenty Seventh (27th) Annual General Meeting (“AGM”) of the Members
of PAR DRUGS AND CHEMICALS LIMITED (“the Company”) will be held on Saturday, 26th Day of
September, 2026 at 11:00 A.M. at Hotel Tara Suns, B/h Yash Complex, B/s Sonal Park, G.E.R.I. Road, Gotri,
Vadodara -390021, Gujarat, India to transact the following business to transact the following business:
ORDINARY BUSINESS:
ITEM NO.1: To receive, consider and adopt the Audited Standalone Financial Statements of the
company for the financial year ended on 31st March, 2026 together with the report of the
Board of Directors and Auditors thereon.
ITEM NO.2: To appoint a Director in place of Mr. Jignesh Vallabhbhai Savani, Director & CEO (DIN:
00198203), who retires by rotation and being eligible offer himself for re-appointment.
ITEM NO.3: To re-appoint statutory auditors of the Company and to fix their remuneration and in this
regard to consider and if thought fit, to pass, with or without modification(s), the following
resolution as an Ordinary resolution:
“RESOLVED THAT pursuant to the provisions of Section 139 and all other applicable provisions, if any, of
the Companies Act, 2013 and the Rules made thereunder, M/s. Sarupria Somani & Associates, Chartered
Accountants (Firm Registration No.: 010674C) be and are hereby re-appointed as the Statutory Auditors
of the Company from the conclusion of this 27th Annual General Meeting till the conclusion of the next
28th Annual General Meeting of the Company to be held for the F.Y. 2026-27 at an annual remuneration
/ fees of ₹ 2,25,000/- (Rupees Two Lakh Twenty Five Thousand Only) plus out of pocket expenses and
taxes as applicable from time to time with the power to the Board/Audit Committee to alter and vary the
terms and conditions of re-appointment, revision including upward revision in the remuneration during
the remaining tenure.”
“RESOLVED FURTHER THAT for the purpose of giving effect to the above resolution, the Board be and is
hereby authorized to do all such acts, deeds, matters and things and take all such steps as may be
necessary, proper or expedient for implementation of the above resolution and matters connected
therewith or incidental thereto including but not limited to delegation of all or any of the powers herein
conferred to any Committee or any director(s) or any other officer(s) of the Company, or to settle any
1 Par Drugs And Chemicals Limited | Annual General Meeting 2026
questions, difficulties or doubts that may arise with regard to the above resolution, without being
required to seek any further clarification, consent or approval of the Members.”
SPECIAL BUSINESS:
ITEM NO.4: To approve the remuneration payable to Mr. Pravin Manjibhai Bhayani (DIN: 08332851)
as an Independent Director of the Company and in this regard to consider and if thought
fit, to pass, with or without modification (s), the following resolution as a Special
resolution:
“RESOLVED FURTHER THAT pursuant to the provisions of Section 149(9), 197(3) and 198 read with
Schedule V and other applicable provisions, if any, of the Companies Act, 2013, Companies (Appointment
and Remuneration of Managerial Personnel) Rules, 2014 and Regulation 17(6)(ca) and other applicable
provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (including any
amendment/modification or re-enactment thereof) and pursuant to the recommendation and approval of
the Nomination and Remuneration Committee and Audit Committee and the approval of the Board of
Directors of the Company, consent of the Members of the Company be and is hereby accorded to for
payment of remuneration to Mr. Pravin Manjibhai Bhayani (DIN: 08332851), Independent Director of the
Company, amounting to ₹ 24 Lakhs (Rupees Twenty-Four Lakhs Only) for the period of one year w.e.f. 1st
October, 2026 to 30th September, 2027, payable on a monthly, quarterly, half yearly or yearly basis, as
decided by the Board of Directors of the Company.
“RESOLVED FURTHER THAT the Board of Directors of the Company may pay the remuneration to Mr.
Pravin Manjibhai Bhayani, Independent Director, DIN: 08332851 whether by way of remuneration,
Commission or any other way and/ or any combination of the same as mutually agreed by the Board and
Mr. Pravin Manjibhai Bhayani.
“RESOLVED FURTHER THAT such remuneration shall exclude all the fees payable to Mr. Pravin Manjibhai
Bhayani for attending the meetings of the Board and Committees of the Board and also exclude the expenses
incurred/reimbursement of expenses for attending the meetings of the Board, the Committees,
Shareholders and such other meetings as organized by the Company from time to time.
“RESOLVED FURTHER THAT any present Directors of the company be and are hereby authorized to do
sign/digitally sign all such necessary forms, documents, papers, and to do all such acts, matters, deeds as
may be required under the Companies Act,
[Showing first 8,000 characters — download PDF for full document]